Synopsis
0
EU WC
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
JDMF 
Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12241
Submission : 1996-12-02
Status :
Type : II
Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-25
Pay. Date : 2013-01-15
DMF Number : 25421
Submission : 2012-03-01
Status :
Type : II
Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18459
Submission : 2005-06-27
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Deferoxamine Mesilate, Produced By Fermentation
Certificate Number : R1-CEP 2000-160 - Rev 04
Status : Valid
Issue Date : 2022-06-17
Type : Chemical
Substance Number : 896
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
Registration Number : 223MF10158
Registrant's Address : NUERNBERGER STRASSE 12, 90537 FEUCHT, GERMANY
Initial Date of Registration : 2011-11-14
Latest Date of Registration : 2011-11-14
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios ...
Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
About the Company : Founded in 1990 in France, Fareva is a global subcontractor providing R&D, production, and packaging services across pharmaceutical, cosmetics, and industrial sectors. Operating in...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
EDQM
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]JP
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
60
PharmaCompass offers a list of Deferoxamine Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deferoxamine Mesylate manufacturer or Deferoxamine Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deferoxamine Mesylate manufacturer or Deferoxamine Mesylate supplier.
PharmaCompass also assists you with knowing the Deferoxamine Mesylate API Price utilized in the formulation of products. Deferoxamine Mesylate API Price is not always fixed or binding as the Deferoxamine Mesylate Price is obtained through a variety of data sources. The Deferoxamine Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Desferal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desferal, including repackagers and relabelers. The FDA regulates Desferal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desferal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Desferal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Desferal supplier is an individual or a company that provides Desferal active pharmaceutical ingredient (API) or Desferal finished formulations upon request. The Desferal suppliers may include Desferal API manufacturers, exporters, distributors and traders.
click here to find a list of Desferal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Desferal DMF (Drug Master File) is a document detailing the whole manufacturing process of Desferal active pharmaceutical ingredient (API) in detail. Different forms of Desferal DMFs exist exist since differing nations have different regulations, such as Desferal USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Desferal DMF submitted to regulatory agencies in the US is known as a USDMF. Desferal USDMF includes data on Desferal's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Desferal USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Desferal suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Desferal Drug Master File in Japan (Desferal JDMF) empowers Desferal API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Desferal JDMF during the approval evaluation for pharmaceutical products. At the time of Desferal JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Desferal suppliers with JDMF on PharmaCompass.
A Desferal CEP of the European Pharmacopoeia monograph is often referred to as a Desferal Certificate of Suitability (COS). The purpose of a Desferal CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Desferal EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Desferal to their clients by showing that a Desferal CEP has been issued for it. The manufacturer submits a Desferal CEP (COS) as part of the market authorization procedure, and it takes on the role of a Desferal CEP holder for the record. Additionally, the data presented in the Desferal CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Desferal DMF.
A Desferal CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Desferal CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Desferal suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Desferal as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Desferal API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Desferal as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Desferal and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Desferal NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Desferal suppliers with NDC on PharmaCompass.
Desferal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Desferal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Desferal GMP manufacturer or Desferal GMP API supplier for your needs.
A Desferal CoA (Certificate of Analysis) is a formal document that attests to Desferal's compliance with Desferal specifications and serves as a tool for batch-level quality control.
Desferal CoA mostly includes findings from lab analyses of a specific batch. For each Desferal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Desferal may be tested according to a variety of international standards, such as European Pharmacopoeia (Desferal EP), Desferal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Desferal USP).
